Latest news
Earnings Release: Here's Why Analysts Cut Their Pacific Biosciences of California, Inc. (NASDAQ:PACB) Price Target To US$2.29 - simplywall.stsimplywall.st · Sat, 08 Aug 2026 14:41:26 GMTPacific Biosciences of California (NASDAQ:PACB) Cut to "Sell" at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:32:14 GMTPACB S-8 & SEC Filings - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 13:10:13 GMTPACB Q2 Deep Dive: Leadership Transition and SPRQ-Nx Rollout Shape Outlook - StockStoryStockStory · Thu, 06 Aug 2026 22:58:55 GMTPACIFIC BIOSCIENCES OF CALIFORNIA, INC. 2026: Revenue $39.01M, EPS ($0.14) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 21:50:20 GMTEDGAR Filing Documents for 0001299130-26-000122 - sec.govsec.gov · Thu, 06 Aug 2026 21:43:51 GMTTD Cowen Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Maintains Target Price $3 - MoomooMoomoo · Thu, 06 Aug 2026 18:22:07 GMTPacBio Q2 Earnings Meet Estimates, Revenues Miss, 2026 Sales View Cut - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 17:04:00 GMT